introduction human gut microbiome associated variety host condition health disease specifically gut bacterial composition shown altered various disease state affect host physiology immune system disease study demonstrated correlation microbiome composition tumor aggressiveness management colorectal cancer crc type cancer parallel study shown different genetic background host e.g. mutation also affect microbiome composition altogether highlight interest studying microbiome composition heredity condition associated gastro-intestinal tumor well type cancer microbiome alteration potentially lead understanding causality improved diagnostic tool affect treatment strategy lynch syndrome one common hereditary cancer syndrome calculated estimated frequency approximately 1:350 western country characterized early onset diverse spectrum cancer mainly crc endometrial cancer account 3–5 incident crc well endometrial cancer worldwide autosomal dominant disorder caused mutation one mismatch repair mmr gene namely mlh1 msh2 msh6 pms2 carrier specific mmr gene mutation show sex- age-related pattern well large phenotypic diversity cancer risk survival phenomenon regarded multifactorial contribution genetic environmental factor druze considered ethnoreligious middle eastern minority group druze worldwide population estimated 1.2 million reside mainly syria lebanon lesser extent jordan usa saudi arabia israel 149,000 druze reside israel according israeli central bureau statistic reported april 24th part religion druze adhered marriage within community addition one born druze—it possible convert druze outside community druze israel reside limited number village mainly north country best knowledge causing mutation among druze family deletion exon position causing early stop codon msh2 gene c.705del p.asp236fs originally described zidan friedman taken together fact druze unique genetic population share similar environment i.e. geographical household dietary make ideal population study phenotypic diversity since microbiome largely affected environment hypothesize analyzing microbiome composition druze population regard genetic predisposition key understanding cancer-microbiome association gut microbiome studied context one study examined fecal colon tissue microbiome composition individual several different mutation leading identified correlation development adenoma another study examined fecal microbiome composition individual sequencing correlated cancer status difference identified study non-significant could explained small sample size low-resolution sequencing method additional study examined fecal microbiome composition female individual crcs endometrial tumor comparing non-ls female individual although study detect microbiome alteration based cancer type successful finding difference individual healthy control indicates possible connection genetic background fecal microbiome present different approach examined fecal microbiome composition individual specific druze community comparing non-ls individual individual carried mutation msh2 without cancer medical history non-ls individual family member carrier study residing household especially important since person-to-person microbiome transmission becoming increasingly evident including family member control enabled meticulous microbiome-based analysis within cohort genetic mutational status focal point divergence minimizing environmental impact microbial diversity performed shotgun metagenomics sequencing comparing microbiome composition non-ls participant within participant correlated microbiome composition regard cancer history record report provide analysis result result cohort consisted druze individual female fig limited number druze community northern israel fig participant patient non-ls participant family member patient residing household participant evaluated body mass index bmi cancer history medication intake fig table median age participant range 23–86 median bmi 26.8 range 19.5–35.4 among participant 66.7 history cancer one non-ls participant history cancer diagnosis year prior recruitment study fig table within participant 55.6 history cancer gastrointestinal tract table within participant history cancer 58.3 diagnosed age table figure participant geographical distribution shown map northern israel acquired google map showing location town sample collected number participant lynch syndrome non-lynch syndrome individual town bar-graphs pie chart presenting cancer history distribution presented filling within non-ls group presented color pie chart presenting gender distribution presented filling within non-ls group presented color full size image table clinical feature history cancer lynch participant full size table shotgun metagenomic sequencing performed sample mean library size 57,473,662 read range 2,978,122–141,078,058 ten abundant genus analyzed metagenomics data presented fig bacterial differential abundance comparison group without cancer history non-ls participant yield statistically significant result however trend observed streptococcus genus enriched group compared non-ls participant faecalibacterium enriched group compared non-ls participant additionally escherichia genus also enriched group compared non-ls participant however enrichment higher group cancer history compared cancer history interestingly bifidobacterium genus enriched non-ls participant group cancer history cancer history figure ten abundant genus relative abundance presented three different group non- lynch syndrome left lynch syndrome without middle right cancer medical history chao1 left shannon right index α-diversity non-lynch syndrome group compared lynch syndrome group data represent median line box iqr box minimum/maximum whisker bray–curtis pcoa sample β-diversity point present one individual sample lynch syndrome status indicated color point cancer history indicated shape point full size image sample α-diversities measured using chao1 sample richness shannon sample richness evenness index found significant difference α-diversity non-ls participant though group showed higher variance fig β-diversity bray–curtis pcoa analysis represents similarity dissimilarity sample sample clustered closer rest sample cluster reveal clear difference group fig fig specific genus specie associated identified using deseq2 wald test alpha 0.05 fdr controlling age sex bmi group analysis whole microbiota revealed several genus specific specie significantly altered group shown fig participant higher relative abundance five streptococcus specie enterococcus genus rothia dentocariosa rothia mucilaginosa akkermansia muciniphila lower abundance intestinibaculum porci megamonas funiformis dialister genus well two dialister species— dialister hominis dialister massiliensis intriguingly lactobacillus delbrueckii higher relative abundance participant relative non-ls control another lactobacillus specie lactobacillus ruminis lower fig table figure volcano plot differential bacterial taxonomic unit abundance sample participant sample non-ls participant red dot indicate differentially abundant bacteria p-value 0.05 log2 fold change 1.5 1.5 respectively detected deseq2 algorithm wald test 0.05 boxplots showing differential abundance four bacterial taxonomic unit participant compared non-ls participant data represent median line box iqr box minimum/maximum whisker wald test 0.05 0.01 full size image next examined correlation microbiome composition cancer history within group within participant specific genus specie associated history cancer identified using deseq2 wald test alpha 0.05 fdr controlling age sex bmi participant cancer history higher relative abundance seven streptococcus specie enterococcus faecalis rothia dentocariosa specie lactobacillus genus additionally participant cancer history lower relative abundance victivallales bacterium specific actinomyces specie propionibacterium acidifaciens alistipes finegoldii well phascolarctobacterium faecium phascolarctobacterium succinatutens fig table figure volcano plot differential bacterial operational taxonomic unit abundance sample participant without history cancer red dot indicate differentially abundant bacteria p-value 0.05 log2 fold change 1.5 1.5 respectively detected deseq2 algorithm wald test 0.05 boxplots showing differential abundance four bacterial taxonomic unit comparing participant depending cancer history status within data represent median line box iqr box minimum/maximum whisker wald test 0.05 0.01 venn diagram showing number percentage bacterial operational taxonomic unit enriched participant enriched history cancer enriched group full size image validate difference identified regarding bacterial taxonomic unit significantly altered vs. non-ls participant driven participant history cancer searched difference microbiome composition within group without history cancer one bacterial specie rothia dentocariosa altered comparing vs. non-ls participant comparing participant based cancer history fig functional level compared functional kegg orthologs abundance non-ls participant cancer history within group total pathway differed significantly non-ls participant deseq2 wald test alpha 0.05 fdr k11130 h/aca ribonucleoprotein complex subunit associated non-ls sample associated highest foldchange compared non-ls k01671 sulfofructosephosphate aldolase k03812 ribosome modulation factor k18919 protein hokc/d k05785 transcriptional antiterminator rfah k19778 acid stress chaperone hdeb k18922 protein hoke fig table among participant found specific associated history cancer fig table result revealed one associated history cancer— k18922 protein hoke one associated history cancer non-ls— k11130 h/aca ribonucleoprotein complex subunit fig figure volcano plot differential kegg orthologs abundance sample participant sample non-ls participant red dot indicate differentially abundant bacteria p-value 0.05 log2 fold change 1.5 1.5 respectively detected deseq2 algorithm wald test 0.05 volcano plot differential abundance sample participant without history cancer red dot indicate differentially abundant bacteria p-value 0.05 log2 fold change 1.5 1.5 respectively detected deseq2 algorithm wald test 0.05 venn diagram showing number percentage enriched participant enriched history cancer enriched group full size image discussion host genetics modulate gut microbiome composition specifically characterized mutation mismatch repair gene shown affect mucosal immunity notably gut microbiome resides intricate relationship mucosal immune system result composition altered predisposes patient cancer however patient develop disease moreover patient even mutation display phenotypic variability age cancer diagnosis cancer location gut microbiome emerged major regulator human health alteration microbiome composition demonstrated plethora disease including crc cancer type altogether led hypothesize gut microbiome altered patient may altered based cancer history chose test hypothesis genetically culturally homogenous community share similar environmental factor resides close proximity geographically cohort included individual family member non-ls control within druze community northern israel find specific operational taxonomic unit otus enriched patient otus decrease abundance dialister genus decreased recently shown over-represented patient advanced lung cancer correlated weak response immunotherapy hand rothia dentocariosa found increased also increased stool lung hematological cancer patient negatively correlated chemotherapy efficacy lactobacillus ruminis decreased demonstrated pro-inflammatory bacteria streptococcus gordonii increased associated tumor tissue healthy tissue oral squamous cell carcinoma notably gordonii associated several study fusobacterium nucleatum well-studied bacteria association malignancy aggressiveness crc well tumor altogether implies type bacteria identified individual previously reported associated cancer cancer aggressiveness potential response therapy within participant find specific otus enriched decreased abundance participant cancer history compared cancer history among bacteria enriched participant without cancer history find phascolarctobacterium bacterial genus previously associated lower level c-reactive protein crp common measure inflammation also find enrichment lactobacillus plantarum extensively studied various disease effect host specifically shown exert anti-inflammatory effect inducing il-10 alleviating inflammatory bowel disease ibd notably bacteria associated low inflammatory state potential anti-inflammatory function align presence participant without cancer history potentially targeted future biomarkers participant lower probability developing cancer parallel streptococcus gallolyticus rothia dentocariosa enriched participant cancer history also shown several study enriched cancer patient specifically gallolyticus shown higher relative abundance crc patient positively correlated higher probability adenoma adenocarcinoma therefore bacteria persistently associated cancer future candidate cancer diagnostics biomarkers therapeutic target example future study may evaluate experimentally whether elimination reduce cancer initiation progression overall comparison analysis vs. non-ls cancer vs. cancer within patient revealed distinct microbial population one bacteria overlapping analysis fig bacteria rothia dentocariosa enriched cancer history relative control thus dentocariosa specifically interesting bacteria future study experimental validation examining possible function cancer initiation uniquely patient analysis functional kegg ortholog abundance pattern participant non-ls revealed difference pathway non-ls participant particularly specific demonstrated distinct association either non-ls sample instance k18922 protein hoke displayed dual association history cancer observation provide valuable insight potential functional disparity related genetic pathway lynch syndrome cancer history within study cohort since one bacteria two overlapped emphasizes enriched bacteria identified patient due overrepresentation cancer history within group note overall alpha beta-diversities significantly different neither group suggesting microbial uniqueness defined otu level analyzing whole microbiome diversity possible larger cohort would enable detection difference alpha beta-diversities well best knowledge study unique multiple aspect focused one specific mutation nonsense mutation msh2 gene study included either mutation several gene multiple different mutation gene studied presumably uniform population—the druze community north israel study compared family member including household member presumably similar genetic background well similar habit diet etc nonetheless family member albeit harboring msh2 mutation differed cancer history depth sequencing performed extremely large enabling high-resolution analysis study focused fecal microbiome individual lynch syndrome characterized relatively small cohort participant inclusion diverse cancer type cross-sectional design precludes exploration dynamic microbiome change time avenue future research furthermore excluded individual undergone antibiotic treatment within six week prior sample collection however aware potential long-term impact antibiotic treatment microbiome composition additional consideration interpreting finding lastly study exclusive focus druze population israel may restrict generalizability finding acknowledge preliminary nature study highlighting need future investigation address limitation refine understanding extend finding broader context result offer insight defined significant microbiome difference unique population well specific microbiome alteration patient history cancer made possible due uniqueness druze community one founder causing mutation focused family household without mutation living identical adjacent geographical region similar environmental condition gave opportunity study categorically microbiome change caused probably ls-mutation genetic background defined otu difference identified examined mechanistically future study may provide novel microbiome-based target diagnostics therapeutic intervention limitation study relatively small sample size cohort inclusion patient developed several type cancer albeit predominantly ls-associated underwent several type treatment i.e chemotherapy surgery immunotherapy limit statistical power study example surgery alone might direct effect microbiome composition however main goal study focus homogenous community regard mutation culture geographical living location led compromise participant cancer type treatment calling study homogenous population larger cohort lastly aspirin demonstrated chemoprevention agent patient used medical practice documented study since israeli gastroenterology association currently endorsing routine use chemoprevention method inclusion criterion consecutive druze individual year age found carry msh2 gene mutation either probands non-ls family member offered participate study participant genotyped harboring germline pathogenic mutation msh2 non-ls biological family member genotyped defined non-ls participant one biological family member defined obligatory negative i.e. subject biological relation family confirmed genotyped negative parent non-biological family member defined non-ls participant based family personal medical history exclusion criterion patient excluded study recent week antibiotic treatment recent surgery week unable unwilling sign form consent standard protocol approval registration patient consent study approved local institutional review board rambam health care campus held accordance relevant guideline regulation helsinki 0129-13 written informed consent obtained included subject prior enrollment accordance declaration helsinki sample collection processing fecal sample self-collected non-lynch individual stool sample cup fecal sample stored within two hour collection otherwise stored delivered hospital research team stored fecal sample sub-sampled without thawing whole fecal sample sub-samples heat inactivated min dna extracted sample using purelink microbiome dna purification kit catalog number a29790 according manufacturer instruction matching negative control sample collected week subject latest endoscopic colonoscopy library preparation dna sample underwent quality control qubit fluorescence analysis determine concentration dna downstream analysis thermofisher cat q32850 library prepared sample library preparation control using illumina tagmentation dna prep streamlined library preparation protocol according manufacturer instruction minimum dna starting mass cycle pcr enrichment ending fragment size idt illumina dna/rna index nextera dna index used illumina idt cat illumina nextera cat sequencing library diluted 96-plex pool validated 100-cycle paired-ends read miseq run illumina cat ms-102-2002 shipping sequencing novaseq mode 96-plex 300-cycle paired-end read run estimated read depth gbp per sample illumina cat final loading concentration sequencing run performed spike-in phix control library illumina cat fc-110-3001 taxonomic profiling sequence data quality control including removal human read performed using kneaddata version 0.12.0 default parameter read passing quality control mapped ncbi nucleotide database using centrifuge taxonomic annotation read obtained using least common ancestor algorithm summarized across read create count per taxon raw count normalized using total sum scaling raw count normalized percentage relative abundance taxonomic data filtered taxon minimum 0.01 relative abundance across sample detection least sample library prep control used ass contamination present data gene function analysis sample conducted using humann 3.8 default setting sample evenly rarified million read resulting uniref90 gene family transformed group using humann_regroup_table tool humann software group refined include community-level data data transformed centered-log ratio statistic bioinformatics statistical analysis sequenced data initially performed using microbiomeanalyst followed comprehensive analysis using package phyloseq vegan deseq2 difference microbial taxon functional profile assessed differential abundance analysis using deseq2 alpha diversity index chao1 shannon compared using kruskal–wallis rank sum test beta diversity distance matrix bray–curtis compared using vegan package function adonis multivariate anova based dissimilarity test visualized using pcoa taxonomy result visualized using package ggplot2 enhancedvolcano palette metbrewer package